SEC Filings
Redmile Fund Crosses 5% In Fate Therapeutics Without Buying More Shares
A change in Fate's outstanding share count triggered the update; Redmile reports 14.99% beneficial ownership.
SEC Filings
A change in Fate's outstanding share count triggered the update; Redmile reports 14.99% beneficial ownership.
SEC Filings
The reporting group still holds more than 12 million shares in the cancer-drug company after October and November sales.
SEC Filings
Malone still reports approximately 4.8% ownership through trusts and an LLC, including more than 13 million shares in his revocable trust.
SEC Filings
Subscriptions keep growing, while a $17.5 million investment valuation gain accounts for much of quarterly profit.
SEC Filings
The finance chief will cover the accounting vacancy until a replacement is appointed, with his CEO move scheduled for January 1, 2027.
SEC Filings
Luxembourg revaluations brought a $499 million tax benefit and a $411 million allowance expense in fiscal 2026.
SEC Filings
The leadership handoff includes a 125% target bonus for the CEO and salary protection that expands around a change in control.
SEC Filings
The one-time retention awards also cover the finance and science chiefs as Myriad seeks better efficiency and financial performance.
SEC Filings
Paramount+ growth accelerated to 21%, while the enlarged company faces $87 billion in gross debt and a costly integration.
SEC Filings
Former-CEO award changes added $20.8 million in expense, while MBX expects its cash and investments to fund operations into 2029.
SEC Filings
Adjusted income rose 50%, while Lantronix kept its forecast for double-digit fiscal-year sales growth.
SEC Filings
Nine-month profit fell to $6.1 million from $28.7 million as SIGA works toward a new U.S. government procurement contract.